Correlation Engine 2.0
Clear Search sequence regions

  • cells (2)
  • glycolysis (2)
  • growth (1)
  • humans (1)
  • mitochondria (1)
  • PDC (4)
  • PDKs (1)
  • PDPs (1)
  • Sizes of these terms reflect their relevance to your search.

    Cancer cells exhibit an altered metabolism which is characterized by a preference for aerobic glycolysis more than mitochondrial oxidation of pyruvate. This provides anabolic support and selective growth advantage for cancer cells. Recently, a new concept has arisen suggesting that these metabolic changes may be due, in part, to an attenuated mitochondrial function which results from the inhibition of the pyruvate dehydrogenase complex (PDC). This mitochondrial complex links glycolysis to the Krebs cycle and the current understanding of its regulation involves the cyclic phosphorylation and dephosphorylation by specific pyruvate dehydrogenase kinases (PDKs) and pyruvate dehydrogenase phosphatases (PDPs). © 2015 UICC.


    Elise Saunier, Chantal Benelli, Sylvie Bortoli. The pyruvate dehydrogenase complex in cancer: An old metabolic gatekeeper regulated by new pathways and pharmacological agents. International journal of cancer. 2016 Feb 15;138(4):809-17

    Expand section icon Mesh Tags

    Expand section icon Substances

    PMID: 25868605

    View Full Text